Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to -$1.0 million.

  • iSpecimen's Cash from Investing Activities fell 45570.68% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$957892.0, marking a year-over-year decrease of 17204.52%. This contributed to the annual value of $2.0 million for FY2024, which is 12738.58% up from last year.
  • Per iSpecimen's latest filing, its Cash from Investing Activities stood at -$1.0 million for Q3 2025, which was down 45570.68% from -$73060.0 recorded in Q4 2024.
  • Over the past 5 years, iSpecimen's Cash from Investing Activities peaked at $2.4 million during Q3 2023, and registered a low of -$8.8 million during Q1 2023.
  • For the 5-year period, iSpecimen's Cash from Investing Activities averaged around -$616349.2, with its median value being -$290841.0 (2021).
  • As far as peak fluctuations go, iSpecimen's Cash from Investing Activities tumbled by 249115.56% in 2023, and later soared by 53421.56% in 2024.
  • iSpecimen's Cash from Investing Activities (Quarter) stood at -$304195.0 in 2021, then tumbled by 439.76% to -$1.6 million in 2022, then surged by 55.96% to -$723043.0 in 2023, then skyrocketed by 89.9% to -$73060.0 in 2024, then crashed by 1268.74% to -$1.0 million in 2025.
  • Its Cash from Investing Activities stands at -$1.0 million for Q3 2025, versus -$73060.0 for Q4 2024 and -$179951.0 for Q3 2024.